HIV and sexual health charity Terrence Higgins Trust (THT) have announced that Dr Rosemary Gillespie will be their new Chief Executive replacing former Chief Executive Sir Nick Partridge.
Dr Gillespie joins the charity from her role as Chief Executive of international HIV awareness charity AVERT. Her previous roles have included Deputy Chief Executive and Director of Policy and Research for Breast Cancer Care, and Chief Executive of the Roy Castle Lung Cancer Foundation.
Dr Gillespie said: “I am delighted to have been appointed as Chief Executive of this outstanding and iconic charity. I look forward to working with staff and volunteers in the next phase of development, growth and innovation, as we face new challenges in the fields of HIV and sexual health, and continuing attempts to eradicate prejudice and discrimination.”
Professor Chris Bones, Chair of Trustees at Terrence Higgins Trust, added: “The Trustees are delighted to have secured Dr Gillespie as the new CEO. She brings a remarkable combination of clinical practice, health management and charity leadership at a critical time for our development. No organisation can stay still in the current economic climate and Dr Gillespie’s track record of successful change and innovation across a number of sectors will help us meet the challenges ahead in both HIV and the wider area of sexual health.”
The recruitment process was provided by executive search firm The Talent Business, working on a pro bono basis.
Kate Harrison, Partner at The Talent Business, said: ”The Talent Business is used to leading ‘C Suite’ talent searches on a daily basis, but it has been a particular pleasure to partner Terrence Higgins Trust in the search for a new CEO. From the outset I believe we had real alignment in what was needed from the future leader of the charity, and both the process and outcome were designed innovatively as a result. I believe the organisation deserves an inspirational leader to help it grow to the next level, and this appointment should help secure a bright future from a bright past.”
Dr Gillespie takes up the post from Tuesday, April 1.In the meantime Paul Ward remains as Acting Chief Executive until March.
You must be logged in to post a comment.